Stay updated on Dupilumab in ABPA Treatment Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A sitewide NIH announcement about website updates and terminology appears above the page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:43:21.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T21:45:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Displaying a 403 Forbidden error page replaces the usual study content and shows a Home link. This indicates restricted access to the study record rather than an update to its content.
    Difference
    18%
    Check dated 2026-09-22T22:33:43.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.6 to v3.7.0, indicating a backend/template update with no evident changes to study details or user interactions.
    Difference
    0.0%
    Check dated 2026-09-15T21:52:58.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.6.6, representing a small patch to the page's metadata. This change does not modify the core study content or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-09-01T18:01:27.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    A line noting NIH funding was added to the study record, indicating NIH grant/contract information for the trial. This addition provides funding context but does not alter the study design or eligibility.
    Difference
    0.0%
    Check dated 2026-08-25T20:17:40.000Z thumbnail image

Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.